Diffusion MRI for Head and Neck Cancer
NCT04251481 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2026-01-22
Summary
The proposed study is to investigate the feasibility of using quantitative diffusion MRI (dMRI) methods for accurate and comprehensive assessment of treatment response. dMRI is a powerful tool to probe treatment-induced change in tumors. It is a unique in vivo imaging technique sensitive to cellular microstructures at the scale of water diffusion length on the order of a few microns. Previous studies have shown that both diffusion coefficient D and diffusional kurtosis coefficient K are promising imaging markers of (i) cell viability which can be used for evaluation of early treatment response. However, it is often underappreciated that these dMRI metrics are not fixed constants, but rather functions of the diffusion time t, D(t) and K(t); their t-dependency is determined by tissue properties, such as cell size and membrane permeability of tissue. D(t) and K(t) of tumors can vary substantially depending on t in the range of diffusion times (30-100 ms) typically used in clinical scan.
Conditions
- Head Cancer Neck
Interventions
- RADIATION
-
PET/MRI with FDG
For the PET/MRI scans, an intravenous (IV) catheter (thin tube) will be used to administer dyes (contrast) for both the MRI and PET portions of the examination. The dye for the PET portion will be 18F-fluorodeoxyglucose (FDG). FDG is an FDA-approved radioactive substance (isotope) that contains chemicals that can be traced by PET/MRI. The dye for the MRI portion will be a gadolinium based contrast medium which is also an FDA-approved substance that makes certain tissues, abnormalities or disease processes more clearly visible on MRI scans. MRI uses a strong magnetic field to create images of the body. Subjects will be asked to lie on a table that will slide into the scanner; Wear earplugs to reduce the noise made by the MRI scanner and lie still throughout the time in the scanner.
- RADIATION
-
MRI scan without contrast
MRI uses a strong magnetic field to create images of the body. Subjects will be asked to lie on a table that will slide into the scanner to scan the neck ; Wear earplugs to reduce the noise made by the MRI scanner and lie still throughout the time in the scanner.
- RADIATION
-
MRI with gadolinium
For the MRI scans, an intravenous (IV) catheter (thin tube) will be used to administer dyes (contrast) for MR scans. The dye for the MRI will be a gadolinium based contrast medium which is also an FDA-approved substance that makes certain tissues, abnormalities or disease processes more clearly visible on MRI scans. MRI uses a strong magnetic field to create images of the body. Subjects will be asked to lie on a table that will slide into the scanner; Wear earplugs to reduce the noise made by the MRI scanner and lie still throughout the time in the scanner.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Elcin Zan, MD · NYU Langone
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-16
- Primary Completion
- 2026-04-30
- Completion
- 2026-04-30
Countries
- United States
Study Locations
More Related Trials
-
Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
NCT00313027 ·Status: COMPLETED ·Phase: NA
-
PET-CT vs DWI-MRI in Response Evaluation in Esophageal Cancer
NCT02839109 ·Status: COMPLETED
-
Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI
NCT03656250 ·Status: COMPLETED
-
Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma
NCT02515084 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma
NCT01836484 ·Status: COMPLETED
-
Quantitative MR Imaging in Locally Advanced Cervical Cancer
NCT03210428 ·Status: UNKNOWN
-
18F-FDG PET/CT Versus 18F-FDG PET/MRI in Detecting Locoregional Recurrence 3 Months After CRT in Head and Neck SCC
NCT04196985 ·Status: UNKNOWN ·Phase: NA
-
Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
NCT06914999 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI
NCT02180308 ·Status: COMPLETED
-
The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer Patients
NCT05855278 ·Status: COMPLETED ·Phase: NA
-
Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET
NCT00180245 ·Status: COMPLETED
-
Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer
NCT02527057 ·Status: UNKNOWN
-
Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma
NCT01411579 ·Status: COMPLETED
-
PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning
NCT03286972 ·Status: TERMINATED
-
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
NCT00416455 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
NCT00388024 ·Status: COMPLETED
-
Diffusion-weighted Magnetic Resonance Imaging in Post Therapy Patients With Lymphoma
NCT03969381 ·Status: UNKNOWN
-
Total-Body FDG PET for Radiotherapy Response Assessment in Head and Neck Cancer
NCT05625217 ·Status: COMPLETED ·Phase: NA
-
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
NCT00721799 ·Status: COMPLETED ·Phase: PHASE2
-
Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment
NCT06108089 ·Status: RECRUITING
-
Measurement of Head and Neck Tumor Hypoxia With PET-MRI
NCT05246475 ·Status: RECRUITING ·Phase: NA
-
Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis
NCT01974804 ·Status: COMPLETED
-
PET/MR in Radiotherapy for Head and Neck Cancer Pilot
NCT02952625 ·Status: COMPLETED ·Phase: NA
-
The Role of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes of Head-and-Neck Cancer Patients
NCT00184860 ·Status: COMPLETED ·Phase: NA
-
Role of PET/MRI in Head and Neck Cancer
NCT04360993 ·Status: COMPLETED